RecallDepth
Class III Ongoing

Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
May 16, 2024
Posted
June 12, 2024
Recall Number
D-0542-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,360 units
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: M310493, Exp. Date 01/2025; M308397, Exp. Date 11/2024; M305337, Exp. Date 10/2024; M400155, Exp. Date 06/2025; M314660, Exp. Date 05/2025

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class III Drug recalls